Shenzhen, Guangdong, China In 2015 was created Yuce Biological Technology, which is appeared as Corporate Investor. The fund was located in Asia if to be more exact in China. The leading representative office of defined Corporate Investor is situated in the Shenzhen.
Deals in the range of 50 - 100 millions dollars are the general things for fund. The fund is constantly included in less than 2 deals per year. The high activity for fund was in 2019.
Among the most successful fund investment fields, there are Non Profit, Association. For fund there is no match between the country of its foundation and the country of its the most frequent investments - United States. Besides, a startup needs to be aged 6-10 years to get the investment from the fund. Among the various public portfolio startups of the fund, we may underline MabPlex International
The usual cause for the fund is to invest in rounds with 8 partakers. The meaningful sponsors for the fund in investment in the same round are Thousand Oaks Biopharmaceuticals, Shenzhen Capital Group, SDIC Venture Capital.
Related Funds
| Fund Name | Location |
| AzurInvest | - |
| BancBoston Capital | Boston, Massachusetts, United States |
| EDINA | - |
| ePartners | Irving, Texas, United States |
| Fucheng Touzi | China, Guangdong Province, Guangzhou City |
| FundedHere | Central, Central Region, Singapore |
| Hercules Bioventure Partners | California, Saratoga, United States |
| Innova Capital Consultoria Ltda (Brazil) | Brazil, São Paulo, Sao Paulo |
| Lifetech Scientific Co, Ltd | China, Guangdong, Shenzhen |
| Maricopa County Industrial Development Authority | Arizona, Phoenix, United States |
| Nicoya Ventures | - |
| Northern Gulf Partners | New York, New York, United States |
| Ohio Third Frontier | Columbus, Ohio, United States |
| PepsiCo | New York, New York, United States |
| SEI | SEI Ventures (NASDAQ: SEIC) | Oaks, Pennsylvania, United States |
| UCF Medical Investment | - |
| Webmaker Partners | - |
| ZIG Capital | New York, New York, United States |
Notable deals
| Company | Industry | Round Size | Date | Investors | Location |
MabPlex International | $61M | 17 Jan 2019 | Fremont, California, United States |
1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.
2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.
3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.
4. We can moderate comments at any time.
5. While commenting, you are under the rule of our website’s terms of use and privacypolicy.
6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.
Review
- No reviews are submitted yet.
Sign up and get access to full fund profile and advanced analysis.
Full teamIndustries heatmapStages heatmapGeorgaphy breakdownCoinvestorsPortfolio analysisPerformance indexesLatest highlights
Unlock all data Latest deals
| Company | Industry | Round Size | Date | Investors | Location |
MabPlex International | $61M | 17 Jan 2019 | Fremont, California, United States |
